These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Hendricks RL; Epstein RJ; Tumpey T Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358 [TBL] [Abstract][Full Text] [Related]
8. Spread of HSV and establishment of latency after corneal infection in inbred mice. Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Ksander BR; Hendricks RL Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1986-93. PubMed ID: 2824400 [TBL] [Abstract][Full Text] [Related]
10. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity. Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073 [TBL] [Abstract][Full Text] [Related]
11. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains. Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686 [TBL] [Abstract][Full Text] [Related]
12. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection. Carter C; Easty DL Br J Ophthalmol; 1981 Feb; 65(2):77-81. PubMed ID: 6257272 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102 [TBL] [Abstract][Full Text] [Related]
14. Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci. Lopez C Immunogenetics; 1980 Jul; 11(1):87-92. PubMed ID: 6254873 [TBL] [Abstract][Full Text] [Related]
15. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH; Oakes JE; Lausch RN Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037 [TBL] [Abstract][Full Text] [Related]
16. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. McLeish W; Rubsamen P; Atherton SS; Streilein JW Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960 [TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis. Meyers-Elliott RH; Chitjian PA; Billups CB Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1170-80. PubMed ID: 3036742 [TBL] [Abstract][Full Text] [Related]
18. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. Shimeld C; Hill TJ; Blyth WA; Easty DL J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001 [TBL] [Abstract][Full Text] [Related]
19. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Hendricks RL; Tumpey TM Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289 [TBL] [Abstract][Full Text] [Related]
20. Herpetic keratitis in inbred mice. Metcalf JF; Michaelis BA Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1222-5. PubMed ID: 6480298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]